Latest kidney diseases Stories
-- CHABLIS-SC1 study passes futility analysis and will continue to completion with an enhanced endpoint HAYWARD, Calif., Feb.
According to the new report from BCC Research, the in vitro diagnostic of the renal biomarker market was $771 million in 2013 and is predicted to reach over $1.1 billion globally by 2019, with
Leading dialysis manufacturer invites healthcare professionals to educational event on NxStage System One's first-of-its-kind clearance for overnight therapy LAWRENCE, Mass., Feb.
FREMONT, Calif., Feb. 2, 2015 /PRNewswire/ -- Ardelyx, Inc.
EUGENE, Ore., Feb.
Users Can Now Easily View Favorite Kidney Disease Resources While On-The-Go DENVER, Jan.
GLENDALE, Calif., Jan.
SAN DIEGO and MARCY L'ETOILE, France, Jan.
STOCKHOLM, January 21, 2015 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, announces that its IND for Nefecon(R) is now
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.